These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31694876)

  • 1. The Positive Allosteric Modulator of
    Witkin JM; Li G; Golani LK; Xiong W; Smith JL; Ping X; Rashid F; Jahan R; Cerne R; Cook JM; Jin X
    J Pharmacol Exp Ther; 2020 Jan; 372(1):83-94. PubMed ID: 31694876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioisosteres of ethyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo [1,5-a][1,4]diazepine-3-carboxylate (HZ-166) as novel alpha 2,3 selective potentiators of GABA
    Witkin JM; Smith JL; Ping X; Gleason SD; Poe MM; Li G; Jin X; Hobbs J; Schkeryantz JM; McDermott JS; Alatorre AI; Siemian JN; Cramer JW; Airey DC; Methuku KR; Tiruveedhula VVNPB; Jones TM; Crawford J; Krambis MJ; Fisher JL; Cook JM; Cerne R
    Neuropharmacology; 2018 Jul; 137():332-343. PubMed ID: 29778948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural Analogs of the GABAkine KRM-II-81 Are Orally Bioavailable Anticonvulsants without Sedation.
    Pandey KP; Divović B; Rashid F; Golani LK; Cerne R; Zahn NM; Meyer MJ; Arnold LA; Sharmin D; Mian MY; Smith JL; Ping X; Jin X; Lippa A; Tiruveedhula VVNPB; Cook JM; Savić MM; Witkin JM
    J Pharmacol Exp Ther; 2023 Apr; 385(1):50-61. PubMed ID: 36746611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The α2,3-selective potentiator of GABA
    Witkin JM; Cerne R; Davis PG; Freeman KB; do Carmo JM; Rowlett JK; Methuku KR; Okun A; Gleason SD; Li X; Krambis MJ; Poe M; Li G; Schkeryantz JM; Jahan R; Yang L; Guo W; Golani LK; Anderson WH; Catlow JT; Jones TM; Porreca F; Smith JL; Knopp KL; Cook JM
    Pharmacol Biochem Behav; 2019 May; 180():22-31. PubMed ID: 30825491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Imidazodiazepine Analogue, 5-(8-Bromo-6-(pyridin-2-yl)-4
    Sharmin D; Divović B; Ping X; Cerne R; Smith JL; Rezvanian S; Mondal P; Meyer MJ; Kiley ME; Arnold LA; Mian MY; Pandey KP; Jin X; Mitrović JR; Djorović D; Lippa A; Cook JM; Golani LK; Scholze P; Savić MM; Witkin JM
    ACS Chem Neurosci; 2024 Feb; 15(3):517-526. PubMed ID: 38175916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imidazodiazepine Anticonvulsant, KRM-II-81, Produces Novel, Non-diazepam-like Antiseizure Effects.
    Knutson DE; Smith JL; Ping X; Jin X; Golani LK; Li G; Tiruveedhula VVNPB; Rashid F; Mian MY; Jahan R; Sharmin D; Cerne R; Cook JM; Witkin JM
    ACS Chem Neurosci; 2020 Sep; 11(17):2624-2637. PubMed ID: 32786313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The imidazodiazepine, KRM-II-81: An example of a newly emerging generation of GABAkines for neurological and psychiatric disorders.
    Witkin JM; Lippa A; Smith JL; Jin X; Ping X; Biggerstaff A; Kivell BM; Knutson DE; Sharmin D; Pandey KP; Mian MY; Cook JM; Cerne R
    Pharmacol Biochem Behav; 2022 Feb; 213():173321. PubMed ID: 35041859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The α2,3-selective potentiators of GABA
    Biggerstaff A; Kivell B; Smith JL; Mian MY; Golani LK; Rashid F; Sharmin D; Knutson DE; Cerne R; Cook JM; Witkin JM
    Pharmacol Biochem Behav; 2020 Sep; 196():172996. PubMed ID: 32668266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy Models.
    Leclercq K; Matagne A; Provins L; Klitgaard H; Kaminski RM
    J Pharmacol Exp Ther; 2020 Jan; 372(1):11-20. PubMed ID: 31619464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism, pharmacokinetics, and anticonvulsant activity of a deuterated analog of the α2/3-selective GABAkine KRM-II-81.
    Golani LK; Divović B; Sharmin D; Pandey KP; Mian MY; Cerne R; Zahn NM; Meyer MJ; Tiruveedhula VVNPB; Smith JL; Ping X; Jin X; Lippa A; Schkeryantz JM; Arnold LA; Cook JM; Savić MM; Witkin JM
    Biopharm Drug Dispos; 2022 Apr; 43(2):66-75. PubMed ID: 35194800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative anticonvulsant activity of the GABAkine KRM-II-81 and a deuterated analog.
    Ping X; Meyer MJ; Zahn NM; Golani LK; Sharmin D; Pandey KP; Revanian S; Mondal P; Jin X; Arnold LA; Cerne R; Cook JM; Divović B; Savić MM; Lippa A; Smith JL; Witkin JM
    Drug Dev Res; 2023 May; 84(3):527-531. PubMed ID: 36748904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of human epileptic tissue in the characterization and development of novel antiepileptic drugs: The example of CERC-611 and KRM-II-81.
    Witkin JM; Ping X; Cerne R; Mouser C; Jin X; Hobbs J; Tiruveedhula VVNPB; Li G; Jahan R; Rashid F; Kumar Golani L; Cook JM; Smith JL
    Brain Res; 2019 Nov; 1722():146356. PubMed ID: 31369732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pronounced antiseizure activity of the subtype-selective GABA
    Gurrell R; Iredale P; Evrard A; Duveau V; Ruggiero C; Roucard C
    CNS Neurosci Ther; 2022 Nov; 28(11):1875-1882. PubMed ID: 35965432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the α2/α3-subtype-selective GABAA receptor positive allosteric modulator KRM-II-81 on pain-depressed behavior in rats: comparison with ketorolac and diazepam.
    Moerke MJ; Li G; Golani LK; Cook J; Negus SS
    Behav Pharmacol; 2019 Aug; 30(5):452-461. PubMed ID: 30640180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive Effects of a Novel α2/α3-Subtype Selective GABA
    Lewter LA; Fisher JL; Siemian JN; Methuku KR; Poe MM; Cook JM; Li JX
    ACS Chem Neurosci; 2017 Jun; 8(6):1305-1312. PubMed ID: 28150939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new pyrrolyl-quinoxalinedione series of non-NMDA glutamate receptor antagonists: pharmacological characterization and comparison with NBQX and valproate in the kindling model of epilepsy.
    Löscher W; Lehmann H; Behl B; Seemann D; Teschendorf HJ; Hofmann HP; Lubisch W; Höger T; Lemaire HG; Gross G
    Eur J Neurosci; 1999 Jan; 11(1):250-62. PubMed ID: 9987029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of KRM-II-81, positive allosteric modulator for α2/3 subunit containing GABA
    Nakakubo S; Hiramatsu Y; Goto T; Kimura S; Narugami M; Nakajima M; Ueda Y; Shiraishi H; Manabe A; Sharmin D; Cook JM; Egawa K
    Front Pharmacol; 2023; 14():1273633. PubMed ID: 37849734
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.
    Carter RB; Wood PL; Wieland S; Hawkinson JE; Belelli D; Lambert JJ; White HS; Wolf HH; Mirsadeghi S; Tahir SH; Bolger MB; Lan NC; Gee KW
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1284-95. PubMed ID: 9067315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of hippocampal low-frequency stimulation on GABA
    Xu K; Liu Z; Wang L; Wu G; Liu T
    Brain Res; 2018 Nov; 1698():195-203. PubMed ID: 30118718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.